Dear Mr. Buffett: Healthcare Isn’t Hopeless
Truth is, there are hugely positive tailwinds at our back. But the way we’ve been thinking about the problem is holding us back from solving it. Here’s why.
How healthcare organizations can be their best selves despite the winds of change
At an NEJM Catalyst leadership event earlier this month, Intermountain Healthcare CEO Marc Harrison and Virginia Mason Health System CEO Gary Kaplan outlined how healthcare organizations can thrive during times of change.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.